Federation des caisses Desjardins du Quebec’s CytomX Therapeutics CTMX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q2
Sell
-2,650
Closed -$75.4K 2168
2018
Q1
$75.4K Buy
+2,650
New +$75.4K ﹤0.01% 1226